PARP inhibitor rescues hearing and hair cell impairment in Cx26‐null mice

Xiaohui Wang,Sen Chen,Yue Qiu,Kai Xu,Xue Bai,Le Xie,Weijia Kong,Yu Sun
DOI: https://doi.org/10.1002/VIW.20230066
2023-08-28
View
Abstract:The corresponding pathway mechanism of hair cell (HC) death in Cx26‐null mice involves parthanatos, which contributes to HC loss. The use of poly‐(ADP‐ribose) polymerase inhibitors effectively alleviated both deafness and HC loss in these mice. These findings suggest a promising new target for clinical application, which could aid patients in their pursuit of treatment for GJB2‐related deafness. GJB2 (encoding connexin26, Cx26) mutation is the most common genetic cause of hereditary deafness. Cochlear sensory hair cell (HC) death is the core pathologic phenomenon of GJB2‐related deafness. However, mechanism‐based therapy is still obscure. A targeted‐cell conditional Gjb2 knockout mouse model was established in which the Cx26 in Deiters cells and pillar cells were knocked out at birth. We explored the mechanism of HC death caused by deficiency of GJB2 in supporting cells (SCs), which exhibited moderate deafness, early HC death without SCs, and a decrease in distortion product otoacoustic emission. Here, a DNA damage response was observed in HCs during the onset of hearing loss. Apoptosis, necroptosis, and ferroptosis do not contribute to the death of HCs. We identified and demonstrated that parthanatos, a poly‐(ADP‐ribose) polymerase (PARP)‐dependent and caspase‐independent form of cell death, is a mechanism of HC degeneration. Furthermore, we observed that the use of PARP inhibitors effectively alleviated both deafness and HC loss. Our study reveals the specific mechanism of HC death caused by GJB2 deficiency. These findings demonstrate that targeting parthanatos is an HC protective strategy in the prevention of GJB2‐related hereditary deafness.
materials science, biomaterials,nanoscience & nanotechnology
What problem does this paper attempt to address?